Leukemia, Myeloid, Acute: all 3,035 studies
Page 2 of 31. Open to participants first (746), then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety of Autologous Peptide-induced Active Immunity in AML Maintenance TherapyRecruitingNCT07551037Phase 1
- Phase I Study Of PLM-102 In Patients With Relapsed And Refractory Acute Myeloid LeukemiaNot yet recruitingNCT07549464Phase 1
- Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell TransplantationRecruitingNCT07548983Phase 1
- Study of SA+X in the Treatment of Newly Diagnosed AMLRecruitingNCT07548710Phase 2
- Leukemia Stem Cell-based Assay to Predict Relapse and Survival in Patients With Acute Myeloid LeukemiaRecruitingNCT07537738
- VEN+IDAC vs IDAC in AMLEnrolling by invitationNCT07537257Phase 2/3
- Proton-Based Total Marrow Irradiation for Allogeneic Transplantation in High-Risk AML/MDSRecruitingNCT07532824Phase 1/2
- Evaluation of Antibiotic Prophylaxis in Myelodysplastic Syndromes and Acute Myeloid Leukemia (MYELO-CAN:ABX)Not yet recruitingNCT07528417Phase 2
- Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic MalignanciesRecruitingNCT07523555Phase 1/2
- ABC Maintenance Therapy for AMLNot yet recruitingNCT07521124Not applicable
- Phase I Clinical Trial of ThINKK Adoptive Immunotherapy After Allogeneic Hematopoietic Transplantation in Children With Leukemia or NeuroblastomaNot yet recruitingNCT07518654Phase 1
- my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young AdultsNot yet recruitingNCT07516353Not applicable
- Venetoclax-Azacitidine in Combination With Chidamide and CAG in Fit Older Patients With Acute Myeloid LeukaemiaRecruitingNCT07514936Phase 3
- VA-CIG Regimen for Previously Untreated Acute Myeloid Leukemia: A Multicenter Prospective Single-Arm TrialRecruitingNCT07514832Phase 2
- WearAble Technology for Collecting Health Data in People Who Are the Transfused (WATCH Transfused) - A UK Exploratory Study to Improve Quality of Life and the Efficacy of Transfusion Supportive Care in People With Blood Cancers Undergoing TreatmentRecruitingNCT07511829
- Axatilimab Combined With Decitabine/Venetoclax for the Treatment of TP53-mutated AMLNot yet recruitingNCT07511062Phase 1
- Exploratory Study of Venetoclax, Homoharringtonine, Azacitidine Plus G-CSF for Newly Diagnosed AML (VHAG)Not yet recruitingNCT07507825Phase 2
- Efficacy and Safety of Lisafotoclax Plus Decitabine and Homoharringtonine in Venetoclax/Azacitidine Pretreated AML PatientsNot yet recruitingNCT07505160Phase 2
- A Single-arm, Prospective Study of a Clad-LABU Conditioning Regimen in HSCT for R/R MDS/AML in Elderly PatientsRecruitingNCT07500753Not applicable
- Digital PCR of CHIP and MR for MRD Monitoring After Allo-HSCT in AMLRecruitingNCT07500441
- MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological DiseasesRecruitingNCT07493538Phase 2
- Aclarubicin Plus With Azacitidine and Venetoclax in the Treatment of Acute Myeloid LeukemiaNot yet recruitingNCT07486726Phase 1/2
- Olutasidenib DDI Study in Patients With IDH1 Mutation Positive MalignanciesRecruitingNCT07486713Phase 4
- Venetoclax, Azacitidine, and Mitoxantrone Hydrochloride Liposome Versus Idarubicin and Cytarabine in Newly Diagnosed AMLNot yet recruitingNCT07486479Phase 3
- HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy SurvivorsNot yet recruitingNCT07483749
- Azacytidine, Venetoclax Plus Minus Quizartinib for First Line Older/Unfit AML Patients (VENP-A-QUI)RecruitingNCT07478991Phase 3
- Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical TrialsEnrolling by invitationNCT07474051
- Olutasidenib in Relapsed IDH1 Mutated AML Patients Who Have Previously Received VenetoclaxRecruitingNCT07471841Phase 2
- Safety and Efficacy of GYA01 (CART84) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Acute Lymphoblastic T Leukemia Patients (T-ALL).RecruitingNCT07471789Phase 1/2
- eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell TransplantationRecruitingNCT07469592Not applicable
- VAH vs VA in Newly Diagnosed Elderly AMLNot yet recruitingNCT07469046Phase 3
- CART123 Cells With or Without Ruxolitinib in Relapsed/Refractory Acute Myeloid LeukemiaRecruitingNCT07464951Phase 1
- Study Evaluating the Efficacy and Safety of the Addition of Ivosidenib to Oral Azacitidine (Onureg®) in Patients Over 55 With Acute Myeloid Leukemia (AML) and IDH1 Mutation, in Complete Remission After Intensive Chemotherapy.Not yet recruitingNCT07463768Phase 2
- MRD-guided Maintenance Post-HCT: Gilteritini vs SorafenibRecruitingNCT07463651Phase 3
- Venetoclax Plus Hypomethylating Agents and Subcutaneous Cytarabine for CEBPA-Mutated AMLRecruitingNCT07451912Phase 1/2
- Symptom Cluster Heterogeneity and Gut Microbiota Mechanisms in Childhood Cancer SurvivorsRecruitingNCT07450872
- IFN-α in Relapse Prevention.Not yet recruitingNCT07449286Phase 2
- A Clinical Study to Explore the Safety and Efficacy of CT1390B in Relapsed/ Refractory Acute Myeloid LeukemiaNot yet recruitingNCT07441980Phase 1
- Assessing PI3K Gamma Inhibition With Azacitidine, Venetoclax and Eganelisib in Patients With Acute Myeloid LeukemiaRecruitingNCT07439211Phase 1
- Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)RecruitingNCT07437950Phase 2
- Clinical Study on the Safety, Efficacy and Pharmacokinetics of Universal CLL1 Chimeric Antigen Receptor T-Cell in Relapsed/Refractory Acute Myeloid LeukemiaNot yet recruitingNCT07432100Phase 1
- FLT3-ITD Targeted Therapy in Fit AML PatientsNot yet recruitingNCT07425808Phase 2/3
- Venetoclax Combined With Azacitidine for Consolidation Therapy in AMLRecruitingNCT07425782Phase 2
- A Study of Cladribine, Low Dose Cytarabine, and Venetoclax in Treatment of Relapsed/Refractory or Secondary Acute Myeloid LeukemiaNot yet recruitingNCT07423104Phase 2
- Design and Validation of a Generative AI and Propensity Score Matching Model for the VEN-DEC Phase II Study in Elderly AML Eligible for Allo-SCT; Evaluation of an Exploratory Approach Respect to a Randomized Phase III TrialRecruitingNCT07420790
- Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid TumorsRecruitingNCT07410494Phase 1/2
- Shortened Venetoclax Duration Based on Day 14 BM Blasts Versus Standard Therapy in Elderly or Frail Patients With AML Patients Treated With Azacitidine Plus VenetoclaxNot yet recruitingNCT07407660Phase 3
- VAG Versus Standard Chemotherapy With FLT3 Inhibitor in Adult Patients With FLT3-Mutated AMLNot yet recruitingNCT07407140Phase 3
- Motixafortide for MRD Sensitization in AMLRecruitingNCT07392970Phase 2
- A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid LeukemiaRecruitingNCT07392242Phase 2
- Effect of Hypnosis and Virtual Reality on Anxiety During Treatment for Acute Myeloid LeukemiaNot yet recruitingNCT07386392Not applicable
- First-in-human (FIH) Trial of GEN3018 in Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-risk Myelodysplastic Syndrome (HR-MDS)RecruitingNCT07384715Phase 1
- Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AMLRecruitingNCT07374029Phase 1
- GRanulocyte Augmented Cord Blood Transplantation for Poor Risk leukaEmiaNot yet recruitingNCT07372885Phase 1/2
- Clinical Study of Anti-CLL1-CD33-NKG2D Bicephali CAR-T for Relapsed/Refractory Acute Myeloid LeukemiaNot yet recruitingNCT07370064Phase 1/2
- Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic MalignanciesRecruitingNCT07366801Phase 2/3
- A Study of Revumenib and Mezigdomide in People With LeukemiaRecruitingNCT07356154Phase 1/2
- Ziftomenib + Mezigdomide in Adolesc. and Adults w/ R/R AMLRecruitingNCT07355335Phase 1
- CD64 CAR T Cell Therapy in Adults With Relapsed and/or Refractory AMLRecruitingNCT07347418Phase 1
- A Phase 1 Study of CG009301 for Injection in Adult Subjects With Recurrent or Refractory Haematological MalignanciesRecruitingNCT07347171Phase 1
- Orca-T Expanded Access Program Study for Patients With Advanced Hematologic MalignanciesAvailableNCT07346105
- Clinico-hematological and Coagulation Profiles in Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Intensive Induction Chemotherapy .Not yet recruitingNCT07343687
- Safety and Efficacy of CLL1 CAR-T Followed by Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Relapsed/Refractory Acute Myeloid LeukemiaNot yet recruitingNCT07342244Not applicable
- Quality of Life-Guided Transfusion in Refractory MDS or AMLRecruitingNCT07328191Not applicable
- Romiplostim N01 for Platelet Recovery After Haploidentical HSCTRecruitingNCT07321626Phase 1
- Imetelstat Combinations in Relapsed AMLRecruitingNCT07320235Phase 1
- Pre-DLI or Pro-DLI in Relapsed/Refractory Myeloid Neoplasms After HSCTNot yet recruitingNCT07319793Not applicable
- A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)RecruitingNCT07306832Phase 1
- Post-transplantation Maintenance Therapy With Cidabenamide in Patients With Intermediate/High-risk AMLRecruitingNCT07304232Phase 2
- Olutasidenib With Azacitidine Followed by Olutasidenib Maintenance for the Treatment of IDH1-mutated Acute Myeloid Leukemia in Patients With Prior Treatment With Venetoclax Plus a Hypomethylating AgentRecruitingNCT07304011Phase 2
- A Phase 1b Study of Lonitoclax + Azacitidine in Acute Myeloid Leukemia PatientsRecruitingNCT07303660Phase 1
- TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCTRecruitingNCT07302776Phase 1
- Safety and Feasibility of Sulforaphane to Promote Early Haematopoietic Recovery After Cord Blood TransplantationRecruitingNCT07297576Not applicable
- FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid LeukemiaRecruitingNCT07283094Phase 1
- Phase Ib Study of CD33 FPBMC in Patients With MRD+ AML or MDSRecruitingNCT07270978Phase 1
- Automated vs Manual Flow-cytometry Gating for Measurable Residual Disease in Acute Myeloid Leukaemia (DUALFLOW)Not yet recruitingNCT07269067
- Sorafenib Combined With Venetoclax as Pre-emptive Therapy Strategy for MRD+ AML: a Prospective, Single-arm, Multicenter Clinical StudyNot yet recruitingNCT07264010Phase 2/3
- Clinical Study of LILRA6 CAR-T for the Treatment of R/R Acute Myeloid LeukemiaRecruitingNCT07263906Phase 1
- Gilteritinib Plus VA Followed By Consolidation Chemotherapy in Newly Diagnosed FLT3-ITD+ AMLRecruitingNCT07259707Phase 2
- Feasibility and Safety of Donor-derived NK-cell Infusions for Leukemia Relapse Prophylaxis After Hematopoietic Stem Cell TransplantationRecruitingNCT07256210Phase 2
- A Study of BL-M11D1 in Combination With Cytarabine + Daunorubicin or Venetoclax + Azacitidine in Patients With Acute Myeloid LeukemiaRecruitingNCT07255872Phase 2/3
- Prophylactic DLI-X for Leukemia Relapse After HCTNot yet recruitingNCT07254793Phase 1
- Correlation of Venetoclax Plasma Concentrations With Toxicity of Hypometilating Agents and Venetoclax Combination for Acute Myeloid Leukemia Patients in Remission.RecruitingNCT07254312
- Determination of Epigenetic Markers of Acute Myeloblastic Leukemia in Elderly PatientsRecruitingNCT07250217Not applicable
- Study of NK Cells in the Monitoring of Patients With Acute Leukemia or MyelodysplasiaNot yet recruitingNCT07249476
- Maintenance Venetoclax in AML Fit PatientsRecruitingNCT07244367Not applicable
- Study of the Relationship Between the Pharmacokinetics (PK) and Pharmacodynamics of Venetoclax in Patients With Acute Myeloblastic LeukemiaRecruitingNCT07243483Not applicable
- Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched DonorRecruitingNCT07238712Phase 2
- A Clinical Study to Explore the Safety and Efficacy of CT0991 in Relapsed/ Refractory Acute Myeloid LeukemiaNot yet recruitingNCT07233018Phase 1
- The Efficacy of Therapy in Patients With Acute Myeloid Leukemia and Down Syndrome in RussiaRecruitingNCT07232134Phase 3
- Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid LeukemiaRecruitingNCT07228273Phase 2
- Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)RecruitingNCT07223814Phase 3
- Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromeRecruitingNCT07216443Phase 2
- Venetoclax- Augmented Treosulfan-Based Reduced Intensity Conditioning Before Allogeneic Stem Cell TransplantationNot yet recruitingNCT07214064Phase 2
- Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 MutationRecruitingNCT07211958Phase 3
- High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)RecruitingNCT07205523
- The Effect of Mandala on Anxiety and Fear Levels in Children With Leukemia Before Intrathecal Chemotherapy TreatmentRecruitingNCT07203742Not applicable
- CD123+CLL-1 CAR-T Sequential Infusion With CD7 CAR-T and Bridging to Allo-HSCT for Relapsed/Refractory Acute Myeloid LeukemiaNot yet recruitingNCT07201727Early Phase 1
- A Study of A-CAR028 Treatment in Subjects With Relapsed or Refractory Acute Myeloid LeukemiaRecruitingNCT07198867Phase 1
- Venetoclax-Enhanced BUCY vs. Standard BUCY Conditioning in High-Risk AML and MDS Patients Undergoing Allo-HSCT (Ven-BUCY Study)RecruitingNCT07183878Not applicable